Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
The Agenda for Familial Hypercholesterolemia
2015
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Interventions for renal vasculitis in adults. A systematic review
2010
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
Contrast Medium-Induced Acute Kidney Injury
2015 Standout
A systematic review of LDL apheresis in the treatment of cardiovascular disease
2006
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
Apheresis to treat systemic vasculitis
2017
State of the Art of Low‐density Lipoprotein Apheresis in the Year 2003
2004
Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab
2013
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
The Effects of Endotoxin–Contaminated Dialysate and Polysulfone or Cellulosic Membranes on the Release of TNFα during Simulated Dialysis
1995
Severe and complicated malaria
1990 Standout
Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria
2004 Standout
Silver as Antibacterial Agent: Ion, Nanoparticle, and Metal
2012 Standout
Direct confocal microscopy studies of the bacterial colonization in vitro of a silver-coated heart valve sewing cuff
2000
Dextran‐sulfate‐adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid‐apheresis—Comparison of performance characteristics with DALI and lipidfiltration
2007
Osmotic Nephrosis: Acute Kidney Injury With Accumulation of Proximal Tubular Lysosomes Due to Administration of Exogenous Solutes
2008
In vitro antibacterial properties of magnesium metal against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus☆
2009 StandoutNobel
Very Low Platelet Counts in Post-transfusion Purpura Falsely Diagnosed as Heparin-induced Thrombocytopenia
2000
Antibacterial coatings on titanium implants
2009 Standout
Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients
2007
Evidence‐based treatment of systemic vasculitis
2000
Therapeutic Plasma Exchange for the Treatment of Rapidly Progressive Glomerulonephritis
1997
In face of the increasing efficacy of lipid-lowering therapy, is there still a place for LDL-apheresis?
2004
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
2018
Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis
2007
What’s going on in LDL apheresis
2007
Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis
2010
From Membrane Differential Filtration to Lipidfiltration: Technological Progress in Low‐density Lipoprotein Apheresis
2003
Therapeutic Apheresis for Renal Disorders
2012
The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation
2008
Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients
2002
A review on the wettability of dental implant surfaces II: Biological and clinical aspects
2014 Standout
Therapeutic plasma exchange for refractory SLE: A comparison of outcomes between different sub-phenotypes
2017
Acute Renal Failure
1996 Standout
Lipoprotein-apheresis: Austrian consensus on indication and performance of treatment
2015
Long‐term strategies for the treatment of Refsum's disease using therapeutic apheresis
2012
Efficacy of Antiadhesive, Antibiotic and Antiseptic Coatings in Preventing Catheter-Related Infections: Review
2001
InterGard silver bifurcated graft: Features and results of a multicenter clinical study
2006
Photopheresis in solid organ transplant rejection
2006
Diagnosis and Management of Glomerulonephritis and Vasculitis Presenting as Acute Renal Failure
1990
Antibacterial coatings on haemodialysis catheters by photochemical deposition of silver nanoparticles
2011
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Therapeutic apheresis in renal and metabolic diseases
2000
Immune Thrombocytopenic Purpura
2002 Standout
Rapidly Progressive Glomerulonephritis: Classification, Pathogenetic Mechanisms, and Therapy
1988
Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels – A multicenter observational study
2017
Reduction of periprosthetic infection with silver‐coated megaprostheses in patients with bone sarcoma
2010
Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies
1991
Jugular Vein Catheter Placement: Histologic Features and Development of Catheter-related (Fibrin) Sheaths in a Swine Model
2006
Plasma Exchange for Kidney Disease: What Is the Best Evidence?
2014
Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo
1996
Myasthenia gravis
2019 Standout
Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia
2007
Heparin-induced thrombocytopenia and cardiac surgery
2003 Standout
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Long-term follow-up of aggressively treated idiopathic rapidly progressive glomerulonephritis
1989
Bleeding and thrombotic complications of kidney disease
2011
Apheresis in Coronary Heart Disease With Elevated Lp (a): A Review of Lp (a) As a Risk Factor and Its Management
2007
Plasmapheresis in the Treatment of Rapidly Progressive Glomerulonephritis
1997
Indication of Low‐density Lipoprotein Apheresis in Severe Hypercholesterolemia and its Atherosclerotic Vascular Complications: Dextran Sulfate Cellulose Low‐density Lipoprotein Apheresis
2003
Apheresis for MPO-ANCA-associated RPGN—indications and efficacy: Lessons learned from Japan nationwide survey of RPGN
2005
Critical Observations on the Neurotoxicity of Silver
2007
Efficacy of silver-coated medical devices
1998
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
2007 Standout
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences
2003 Standout
Apheresis for Renal Disease
2001
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: Evidence-based recommendations
1999
Successful treatment of malaria tropica with acute renal failure and cerebral involvement by plasmapheresis and hemodialysis
1988
Review of titanium surface modification techniques and coatings for antibacterial applications
2018 Standout
Traitement par érythrophérèse d'un accès pernicieux palustre
1988
Antibacterial surfaces by adsorptive binding of polyvinyl-sulphonate-stabilized silver nanoparticles
2010
Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems
2001
Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review
2015
The first international consensus conference on continuous renal replacement therapy
2002
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography
2013
Long-term patient survival in ANCA-associated vasculitis
2010 Standout
Intravenous Fluids and Acute Kidney Injury
2017 Standout
Temporary Hemodialysis Catheters as a Long‐term Vascular Access in Chronic Hemodialysis Patients
2005
Prevention of Bloodstream Infections With Central Venous Catheters Treated With Anti-Infective Agents Depends on Catheter Type and Insertion Time: Evidence From a Meta-Analysis
2002
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Antimicrobial effects of silver nanoparticles
2007 Standout
Low‐density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin‐induced thrombocytopenia and thrombosis
2010
Occurrence and antimicrobial resistance of Gram-negative bacteria isolated in haemodialysis water and dialysate of renal units: results of a Greek multicentre study
2003
Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults
2013
Management of Abdominal Aortic Aneurysms Clinical Practice Guidelines of the European Society for Vascular Surgery
2011 Standout
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Low‐density Lipoprotein Apheresis Therapy With a Direct Hemoperfusion Column: A Japanese Multicenter Clinical Trial
2006
Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: A randomised, double‐blind clinical trial
2006
epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England
2013 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
2002 Standout
Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies
1987
A Systematic Review and Meta-Analysis of Systemic Intraoperative Anticoagulation during Arteriovenous Access Formation for Dialysis
2015 StandoutNobel
Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action
2017 Standout
Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults
2016
Successful use of cuffed central venous hemodialysis catheters inserted percutaneously.
1994
Anti-Infective Efficacy of Silver-Coated Medical Prostheses
1999
Therapeutic Potential of Low‐Density Lipoprotein Apheresis in the Management of Peripheral Artery Disease in Patients With Chronic Kidney Disease
2012
The Efficacy of Silver-Ion Implanted Catheters in Reducing Peritoneal Dialysis-Related Infections
2003
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis.
1996
Interventions for renal vasculitis in adults
2015
The Microinflammatory State in Uremia
2001
POST‐TRANSFUSION PURPURA
1986
Corrosion and leaching of silver doped ceramic IBAD coatings on SS 316L under simulated physiological conditions
1998
Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis
2002
Dialysis catheter-related bacteremia: Treatment and prophylaxis
2004
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment
2009 Standout
Metallic implant biomaterials
2014 Standout
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
1990 Standout
Biomaterial Strategies to Reduce Implant-Associated Infections
2007
Plasma Exchange or Immunoadsorption in Patients with Rapidly Progressive Crescentic Glomerulonephritis a Swedish Multi-Center Study
1999
Posttransfusion purpura occurrence and potential risk factors among the inpatient US elderly, as recorded in large M edicare databases during 2011 through 2012
2014
Hematological Problems in Pediatric Intensive Care
2013 Standout
Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
2016
Works of Rolf Bambauer being referenced
Low Density Lipoprotein Apheresis in Treatment of Hyperlipidemia: Experience with Four Different Technologies
2000
Efficacy and Safety of a New Whole‐blood Low‐density Lipoprotein Apheresis System (Liposorber D) in Severe Hypercholesterolemia
2003
Apheresis Technologies: An International Perspective
1995
LDL-apheresis in treatment of two patients with heterozygous familial hypercholesterolemia and extremely elevated lipoprotein (a) levels
1995
Subcutaneous Injection of Desmopressin (DDAVP): Evaluation of a New, More Concentrated Preparation
1989
Complications and Side Effects Associated with Large‐Bore Catheters in the Subclavian and Internal Jugular Veins
1994
Ultrafiltration of Dialysis Fluid to Obtain a Sterile Solution during Hemodialysis
1990
Cyclosporin and plasmapheresis in treatment of progressive systemic lupus erythematosus (pSLE)
1997
Therapeutic Apheresis in the Treatment of Hemolytic Uremic Syndrome in View of Pathophysiological Aspects
2011
Large Bore Catheters with Surface Treatments versus Untreated Catheters for Vascular Access in Hemodialysis
2004
Low‐density Lipoprotein Apheresis: An Overview
2003
Low‐Density Lipoprotein Apheresis: Clinical Results with Different Methods
2002
Silver Coating of Dialysis Catheters to Reduce Bacterial Colonization and Infection
2003
Low–Density Lipoprotein Apheresis in the Treatment of Two Patients with Coronary Heart Disease and Extremely Elevated Lipoprotein (a) Levels
1996
Therapeutic apheresis in autoimmune diseases
2013
Therapeutic Plasma Exchange and Cyclosporine in the Treatment of Systemic Lupus Erythematosus
1999
Side‐effects and Complications in Large‐bore Catheters for Apheresis
2003
Scanning Electron Microscopic Investigation of Catheters for Blood Access
1996
Surface Treated Large Bore Catheters With Silver Based Coatings Versus Untreated Catheters for Extracorporeal Detoxification Methods
1998
Surface Treated Catheters with Ion Beam Based Process for Blood Access
2000
Low-density lipoprotein-apheresis in two patients with extremely elevated lipoprotein (a) levels
1996
Cyclosporin A and Therapeutic Plasma Exchange in the Treatment of Severe Systemic Lupus Erythematosus
2000
Apheresis Technologies for Prevention and Regression of Atherosclerosis
1999
Contamination of Dialysis Water and Dialysate
1994
Therapeutic Apheresis in Hematologic, Autoimmune and Dermatologic Diseases With Immunologic Origin
2016
Scanning Electron Microscopic Investigations of Surface Treated Large-Bore Catheters Used for Extracorporeal Detoxification Methods
1995
Scanning Electron Microscopic Investigation of Catheters for Blood Access
1994
Sterile versus non-sterile dialysis fluid in chronic hemodialysis treatment.
1991
Posttransfusion purpura
1986
LDL-Apheresis: Technical and Clinical Aspects
2012
LDL-Apheresis in Two Patients with Extremely Elevated Lipoprotein (a) Levels
1995
Contamination of Dialysis Water and Dialysate
1994
Four Years’ Treatment Efficacy of Patients with Severe Hyperlipidemia. Lipid Lowering Drugs versus LDL-Apheresis
1995
Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study.
1988
Therapeutischer Plasma-Austausch bei schwer verlaufender Malaria tropica
2008
[Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage].
1991
Comparison of low molecular weight heparin and standard heparin in hemodialysis.
1991
Frequency, Therapy, and Prevention of Infections Associated with Large Bore Catheters
1992